overview
The 11thAnnual Pharma Regulatory Affairs Asia is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region. With a 10-year track record, IBC Asia brings to market the latest developments and key insights from decision makers.
Part of the 5th Annual PharmaCon Asia, meet and network with industry leaders and implementers, and get up-to-speed on the latest insights and case studies in pharma across 4 co-located events.
“The event was beneficial in understanding new therapy areas and challenges which are beyond generic pharmaceuticals.”
– Rakesh Chaurasia, Advisor, Strategic International Regulatory Affairs, PT Dexa Medica
Snapshot of 2018 Attendee List:
Conference Highlights
- Updates on the regulatory harmonization efforts in Asia for pharmaceutical drugs
- Country-specific regulatory updates on the latest guidelines and initiatives
- Global eCTD transition and acceleration in emerging markets and China
- Use of AI in pharmaceutical regulatory operations
- Enhancing launch excellence and cross-functional connections for better regulatory outcomes
- Post-marketing surveillance requirements – best practices for compliance in managing post-approval changes, clinical research, safety
- Global and regional outlook on drug e-labelling initiatives
Choose your language
Part of
Co-Located Events
Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Asia >>
Pharma Market Access and Pricing Summit Asia >>
Digital Pharma Summit >>
Sponsorship
Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.
Partners
speakers
Danny Soon
Senior Director, Health and Biomedical Cluster, Biomedical Research Council (BMRC) A*STAR
Ho Weng Si
Director, Biomedical Sciences Group, Economic Development Board, Singapore
Kurt Scheinpflug
Senior Director of Digital Medicines Engineering, Proteus Digital Health, USA
Enver Erkan
Country Manager, Pfizer Singapore
Alexis Serlin
Asia Cluster Head, Novartis
Miguel Rivera
Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland
How Ti-Hwei
Country President, AstraZeneca, Singapore
Shun Jin
Head, Regulatory Affairs, APMA, Sandoz, Singapore
Finny Liu
Lead of APAC Regional Regulatory Policy, PDR, Roche, Singapore
Hye Jin Choi
Principal, Strategic Clinical Development Consulting Asia Pacific, IQVIA, South Korea
Bruce Sun
Publishing Team Lead (Established Markets), Worldwide Regulatory Operations, Pfizer, China
Silke Nolkemper
General Manager, Director Consulting APAC, EXTEDO, China
Cindy Huang
Senior Technical Specialist, Division of Medicinal Products, Taiwan Food & Drug Administration, Taiwan
Chua Hui Ming
Senior Principal Assistant Director, Biologics Section, Center for Product Registration, National Pharmaceutical Regulatory Division (NPRA), Ministry of Health Malaysia
Theingi Zin
Director (Drug Control), Food & Drug Administration, Ministry of Health & Sports, Myanmar
Sherry Wang
Associate Director, Public Policy & Regulatory Affairs - Southeast Asia, Global External Affairs, United States Pharmacopeia (USP), Singapore
Koichi Miyazaki
Senior Director, Clinical Development Group, Asia Development Department, R&D Division, Daiichi Sankyo, Japan
Catherine Clemente
Associate Drug Regulatory Affairs & Pharmacovigilance Lead, Sandoz, Philippines
Lu Bihong
Head, Regulatory Affairs APAC, UCB Pharmaceuticals, China
May Wei
Vice President, Head of Regulatory, CMC & Production, Moleac, Singapore
Anuradha Arunachalam
Regulatory Affairs and Pharmacovigilance Specialist, Novo Nordisk, Singapore
Jean-Christophe Delumeau
Head of Pharmacovigilance Policy Strategy, Bayer, Singapore
Rie Matsui
Director, Regional Labeling Head for Asia, Pfizer, Japan
Yeo Jing Ping
Director of Research Integrity, Compliance & Ethics, SingHealth, Singapore
Manoj Saxena
Director Regional Market Access, Asia-Pacific, Bayer, Singapore
Hazel Dy Tioco
Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines
Yaron Turpaz
Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore
Harish Dave
Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore
when & where
19 - 20 Sep 2018
One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562
Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com
contact
Still have a question?
Customer Service
register@ibcasia.com.sg
+65 6508 2401
Speaking Opportunities
Genevieve Lim
+65-6508 2472
Genevieve.Lim@ibcasia.com.sg
Sponsorship Opportunities
Yvonne Leong
+65 6508 2489
Yvonne.Leong@ibcasia.com.sg
Media & Association Partnership Opportunities
June Tan
+65 6508 2465
June.Tan@ibcasia.com.sg
